AstraZeneca supports the growth of the C3i Lymphoma Registry, a project led by Dr. Isabelle Fleury at Hôpital Maisonneuve-Rosemont

NEXT STORY
Three New Articles Focus on COVID-19: Diagnosis and Risk Factors
PREV STORY
Kura Oncology Doses First Patient in Phase 1/2 Clinical Trial of Tipifarnib in Combination with Alpelisib in Head and Neck Squamous Cell Carcinoma
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Barrick Sustainability Report Highlights Commitment to ESG

author_avatar
NASDAQ Market News

SIGA Enters into Cooperative Research and Development Agreement with U.S. Army Medical Research Institute of Infectious Disease to Evaluate the Efficacy of TPOXX® as a Post-Exposure Prophylactic for Smallpox

NEW YORK, Oct. 04, 2018 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), ...

author_avatar
NASDAQ Market News

Mateon and Asili Research Alliance Enter Into Partnership for the Development of Artemisinin Against Covid-19

author_avatar
NASDAQ Market News